Joshua Merritt

Joshua Merritt is a Senior Associate Scientist at Incendia Therapeutics, where Joshua focuses on mechanisms of treatment and resistance in IDH1- and FGFR-mutant cholangiocarcinoma. Joshua previously worked as a Research Technician at Bardeesy Lab - Massachusetts General Hospital Cancer Center, Research Associate II at Celsius Therapeutics, and Research Assistant at Fordham University. Additionally, Joshua has experience as a Producer at WFUV Public Radio. Joshua holds a Bachelor's degree in Chemistry and Middle East Studies from Fordham University.